No Result
View All Result
  • Private Data
  • Membership options
  • Login
  • COUNTRY
    • ITALY
    • IBERIA
    • FRANCE
    • UK&IRELAND
    • BENELUX
    • DACH
    • SCANDINAVIA&BALTICS
  • PRIVATE EQUITY
  • VENTURE CAPITAL
  • PRIVATE DEBT
  • DISTRESSED ASSETS
  • REAL ESTATE
  • FINTECH
  • GREEN
  • PREMIUM
    • ItaHubHOT
      • ItaHub Legal
      • ItaHub Tax
      • ItaHub Trend
    • REPORT
    • INSIGHT VIEW
    • Private Data
Subscribe
  • COUNTRY
    • ITALY
    • IBERIA
    • FRANCE
    • UK&IRELAND
    • BENELUX
    • DACH
    • SCANDINAVIA&BALTICS
  • PRIVATE EQUITY
  • VENTURE CAPITAL
  • PRIVATE DEBT
  • DISTRESSED ASSETS
  • REAL ESTATE
  • FINTECH
  • GREEN
  • PREMIUM
    • ItaHubHOT
      • ItaHub Legal
      • ItaHub Tax
      • ItaHub Trend
    • REPORT
    • INSIGHT VIEW
    • Private Data
Home COUNTRY DACH

54 Top Biopharma Startups and Companies in Germany (Taken out: 2)

EU Startupsby EU Startups
October 13, 2023
Reading Time: 8 mins read
in DACH, VENTURE CAPITAL
Share on FacebookShare on Twitter

This article showcases our top picks for the best German startups focusing on Biopharma. These startups and companies are taking a variety of approaches to innovating the Biopharma industry, but are all exceptional companies well worth a follow.

We tried to pick companies across the size spectrum from cutting-edge startups to established brands. We selected these startups and companies for exceptional performance in one of these categories:

  • Innovation: Idea, route to market, product
  • Exceptional growth and strategy
  • Management
  • Social impact

BioNTech: Founded in 2008 in Mainz, BioNTech emphasizes individualized cancer treatments, harnessing advanced platforms like mRNA therapeutics and engineered cell therapies. Their commitment to innovation extends to collaborations and state-of-the-art manufacturing, aiming to globally provide personalized therapies.

Evotec: Life science firm that emphasizes innovative patient therapeutics. They harness the “Data-driven R&D Autobahn to Cures” for collaborative ventures. With 5,000+ professionals at 17 locations, they aim for a leading co-owned therapeutic pipeline.

CureVac: Based in Tübingen, CureVac is listed as CVAC on Nasdaq, and has over 20 years in messenger RNA (mRNA) technology, leveraging it to combat diseases. Through collaborations, like with GSK, they’re innovating in vaccines, cancer treatments, and rare disease therapies. Based in Tübingen, Germany, they operate globally with a robust clinical pipeline.

Cardior-PharmaceuticalsCardior Pharmaceuticals: Cardior Pharmaceuticals, a foremost clinical-stage biopharmaceutical firm, is at the forefront of RNA-based therapies targeting heart diseases. Utilizing unique non-coding RNAs, they target the core issues of cardiac dysfunctions. They aim to offer groundbreaking therapies and diagnostics globally.

Eleva: Based in Freiburg, Eleva develops novel biological therapies with its pharmaceutical partners. The privately-held company leverages its unique moss-based production platform to produce supreme biologics like antibodies, replacement enzymes, or fusion toxins. Eleva has successfully developed drug candidates for clinical phases.

ITMIsotopen Technologien München: Founded in 2004, They specialise in developing and distributing radiopharmaceuticals for targeted cancer treatment. With a global GMP-compliant supply network, they focus on enhancing cancer patient outcomes while reducing side effects through Targeted Radionuclide Therapies. Their innovative approach addresses diverse cancers, partnering globally to improve precision oncology.

Vivoryon Therapeutics: A clinical-stage company dedicated to developing small molecule drugs, leveraging their profound knowledge of disease pathways, with the sole aim of enhancing the lives of individuals suffering from severe illnesses.

Allecra Therapeutics: Founded in 2013, Allecra Therapeutics is a clinical-stage biopharmaceutical firm combatting antibiotic resistance. Their lead product, cefepime/enmetazobactam, outperformed standard cUTI treatments in a global Phase 3 trial, prompting marketing approval preparations in the U.S. and EU.

Rentschler Biopharma SE: A leading CDMO based in Laupheim, with a site in Milford, MA, USA, specializes in biopharmaceutical process development, manufacturing, and consulting, ensuring high-quality solutions for clients. Emphasizing quality management, operational excellence, and advanced tech, they guarantee product excellence.

4SC: Based in Planegg-Martinsried, they focus on resminostat, an oral histone deacetylase inhibitor, for treating various cancers, especially cutaneous T-cell lymphoma (CTCL). CTCL affects around 5,000 Europeans annually, with limited durable treatment options.

Atriva Therapeutics: Dedicated to creating antiviral therapies for severe respiratory diseases like influenza and COVID-19. Their lead product, zapnometinib (ATR-002), uniquely targets the host to curb viral replication, reducing the likelihood of viral resistance. The team blends cutting-edge viral research with industry expertise to advance pandemic readiness.

c-LEcta: Based in Leipzig, specializes in enzyme products for the food and pharmaceutical sectors using its ENESYZ® platform. Serving 400+ customers globally, they’re part of the Kerry Group, a global leader in taste, nutrition, and sustainable solutions with 22,000 employees across 150+ locations.

GeneQuine Biotherapeutics GmbH
GeneQuine Biotherapeutics develops gene therapy for the treatment of osteoarthritis.

LXP Group GmbH
Revolutionary process for utilization of 2G biomass.

Phenex Pharmaceuticals
Phenex Pharmaceuticals is a drug discovery and development company focused on developing novel pharmaceuticals.

Thermosome
Thermosome is developing drug candidates leveraging its proprietary drug delivery technology.

Formycon
Formycon provides formulation and analytical services to the biopharmaceutical industry.

 

– SAVE DRAFT –

Lipocalyx
Lipocalyx GmbH develops transfection reagents for siRNA.

ConoGenetix biosciences
ConoGenetix biosciences is a biotechnology company that focuses on the development of peptide-based drugs.

Sysmex Inostics
Sysmex Inostics is a molecular diagnostics firm that provides testing for physicians, clinical trials, and research.

Dynamic Biosensors GmbH
The company has developed a platform for the analysis of molecular interactions for superior identification of pharmaceutical substances.

Cardion
Cardion is a biopharmaceutical company that develops cardiovascular gene therapy products.

– SAVE DRAFT –

ENT Biotech – Digitized Bioconversion
We digitize bioconversion combining artificial intelligence, robotics, & entomology, reducing the cost of melanin & chitosan.

GPC Biotech
GPC Biotech is a German biopharmaceutical company that discovers and develops anticancer drugs.

Agennix
Agennix is a biopharmaceutical company.

Cellca
Cellca is a technology and service provider developing upstream technologies for mammalian protein manufacturing.

Hyglos
Hyglos GmbH is a biotech company which develops bacteriophage-derived recombinant proteins for detection and removal of harmful bacteria.

– SAVE DRAFT –

Protagen Protein Services
Protagen Protein Services is a global leader in Biosimilars, Proteomics, Protein Characterization, GMP Protein Analysis.

DyNAbind
DyNAbind is a biotech company offers solutions such as dynamic DNA-encoded library for drug discovery process.

aquila biolabs
aquila biolabs is a start-up focusing on the development of innovative laboratory devices for the analysis of shake-flask fermentations.

PRAMOMOLECULAR
PRAMOMOLECULAR is developing self-delivering siRNAs as therapeutic candidates for the treatment of lung and pancreatic cancers.

WILEX
WILEX is a biopharmaceutical company developing drugs and diagnostic agents to detect and treat malignant tumors and cancers.

– SAVE DRAFT –

OctreoPharm Sciences
OctreoPharm Sciences is focused on the development of new radio pharmaceuticals for neuroendocrine tumors.

Jena Bioscience
Jena Bioscience is a distributor of biotechnology products.

ChromoTek
ChromoTek develops immunologic research reagents and tools for the proteomics and cell biology sectors.

Mologen AG
Mologen AG is an internationally operating bio pharmaceutical company.

Radiopharma
Radiopharma engages in nuclear medicine and molecular imaging for the diagnosis and treatment of several diseases.

– SAVE DRAFT –

Cranach Pharma
Cranach Pharma is a pharmaceutical wholesaler.

Affectis Pharmaceuticals
Affectis Pharmaceuticals is a pharmaceuticals company developing novel drugs.

pluriSelect
pluriSelect offers separation technologies for the isolation of cells, proteins, viruses, and bacteria from blood and biological fluids.

Immunolab GmbH
Immunolab manufactures highly sensitive and immuno-diagnostics and analytical reagents in compliance with current quality standards.

Pharmedartis
Pharmedartis focus is on recombinant technologies and protein production.

– SAVE DRAFT –

Galantos Pharma
Galantos Pharma is a drug development company focusing on new drugs for neurodegenerative diseases such as Alzheimer’s Dementia.

Pharmact
Pharmact is the medtech company behind the most leading-edge IVDs aiming at preventing the spread of diseases through early detection.

VAYU Sense
Industrial Internet of Things Solution for Bio Pharma Production Optimization

RESprotect
RESprotect is a bioengineering company committed to the development of pharmaceuticals.

Targos Molecular Pathology
Targos provides the highly standardized environment for clinical biomarker research, development and application.

– SAVE DRAFT –

Rheincell
Rheincell manufactures GMP-compliant generation of human-induced pluripotent stem cells.

BSV BioScience
BSV BioScience focuses on different R&D activities continuously pursuing improvements in the field of API ́s and finished dosage forms.

Rottendorf Pharma
Rottendorf Pharma is a first-class contract development and manufacturing organization.

Bioassay
Bioassay is a company offering creation and implementation of bioanalytical assays in pharmacology, immunology and toxicology.

ASKA Biotech
ASKA Biotech specializes in cell culture, antibodies, protein production, and purification processes.

By the way: If you’re a corporate or investor looking for exciting startups in a specific market for a potential investment or acquisition, check out our Startup Sourcing Service!

Read the orginal article: https://www.eu-startups.com/2023/10/54-top-biopharma-startups-and-companies-in-germany-taken-out-2/

Gateways to Italy

Gateways to Italy – Offer your services to funds and investors willing to explore opportunities in Italy. Become a partner!

Gateways to Italy – Offer your services to funds and investors willing to explore opportunities in Italy. Become a partner!

by Partner
June 6, 2023

Sign up to our newsletter

SIGN UP

Related Posts

Singapore Nuevocor secures a 45 million euros round that Angelini Ventures and Kurma Partners lead
ITALY

Italy’s angels & incubators and venture capital weekly roundup. News from Therini Bio, Angelini Ventures, P101, Civitfun Hospitality, HBX, and more

May 20, 2025
FRANCE

Paris-based EdTech startup PyxiScience raises €2 million to innovate math learning with AI

May 20, 2025
SCANDINAVIA&BALTICS

Danish investor PSV Tech launches a €70 million Fund II to support the next tech giants of the Nordics

May 19, 2025

ItaHub

Crypto-assets supervision rules in Italy, Banca d’Italia will supervise payment systems and Consob on market abuse

Crypto-assets supervision rules in Italy, Banca d’Italia will supervise payment systems and Consob on market abuse

November 4, 2024
Italy’s SMEs export toward 260 bn euros in 2025

Italy’s SMEs export toward 260 bn euros in 2025

September 9, 2024
With two months to go before the NPL Directive, in Italy the securitization rebus is still to be unraveled

With two months to go before the NPL Directive, in Italy the securitization rebus is still to be unraveled

April 23, 2024
EU’s AI Act, like previous rules on technology,  looks more defensive than investment-oriented

EU’s AI Act, like previous rules on technology, looks more defensive than investment-oriented

January 9, 2024

Co-sponsor

Premium

Funds vying for management consulting firm BIP, a CVC portfolio company. All deals in the sector

Funds vying for management consulting firm BIP, a CVC portfolio company. All deals in the sector

March 6, 2025
Private equity, Italy 2024 closes with 588 deals as for investments and divestments from 549 in 2023. Here is the new BeBeez’s report

Private equity, Italy 2024 closes with 588 deals as for investments and divestments from 549 in 2023. Here is the new BeBeez’s report

February 10, 2025
Crypto-assets supervision rules in Italy, Banca d’Italia will supervise payment systems and Consob on market abuse

Crypto-assets supervision rules in Italy, Banca d’Italia will supervise payment systems and Consob on market abuse

November 4, 2024
Venture capital investments top €1.3bn in 208 rounds as of Sep30  in Italy. They were €1.5 in all 2023. The new BeBeez Report

Venture capital investments top €1.3bn in 208 rounds as of Sep30 in Italy. They were €1.5 in all 2023. The new BeBeez Report

October 28, 2024
Next Post

AM Best Withdraws Credit Ratings of ASR Re Limited

German startup NEURA Robotics secures €15 million to become a solution for shortage of skilled workers

EdiBeez srl

C.so Italia 22 - 20122 - Milano
C.F. | P.IVA 09375120962
Aut. Trib. Milano n. 102
del 3 aprile 2013

COUNTRY

Italy
Iberia
France
UK&Ireland
Benelux
DACH
Scandinavia&Baltics

CATEGORY

Private Equity
Venture Capital
Private Debt
Distressed Assets
Real Estate
Fintech
Green

PREMIUM

ItaHUB
Legal
Tax
Trend
Report
Insight view

WHO WE ARE

About Us
Media Partnerships
Contact

INFORMATION

Privacy Policy
Terms&Conditions
Cookie Police

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • COUNTRY
    • ITALY
    • IBERIA
    • FRANCE
    • UK&IRELAND
    • BENELUX
    • DACH
    • SCANDINAVIA&BALTICS
  • PRIVATE EQUITY
  • VENTURE CAPITAL
  • PRIVATE DEBT
  • DISTRESSED ASSETS
  • REAL ESTATE
  • FINTECH
  • GREEN
  • PREMIUM
    • ItaHub
      • ItaHub Legal
      • ItaHub Tax
      • ItaHub Trend
    • REPORT
    • INSIGHT VIEW
    • Private Data
Subscribe
  • Login
  • Cart